Hims & Hers Health Inc HIMS is trading higher Thursday after the company announced better-than-expected second-quarter financial results and issued guidance above estimates.
Hims & Hers Health reported a quarterly earnings loss of 5 cents per share, which beat the estimate for a loss of 10 cents per share. The company reported quarterly revenue of $60.7 million, which beat the estimate of $56.49 million.
Hims & Hers Health expects third-quarter revenue to be in a range of $69 million to $71 million versus the estimate of $58.31 million.
"This was a quarter of very strong execution, as we continued to drive consistent organic revenue growth across our business, from our core categories to the newer mental health services. We also heavily invested in key infrastructure and differentiated technologies," said Andrew Dudum, co-founder and CEO of Hims & Hers Health.
Hims & Hers Health is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care.
Price Action: Hims & Hers Health has traded as high as $25.40 and as low as $7.24 since it went public in January.
At last check Thursday, the stock was up 8.78% at $8.23.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
